WPD Pharmaceuticals Clarifies News on Licensed Drug Candidate [Canadian Business Journal (Canada)]
Moleculin Biotech, Inc. (MBRX)
Last moleculin biotech, inc. earnings: 8/16 05:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
moleculin.com/investors
Company Research
Source: Canadian Business Journal
VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) —WPD Pharmaceuticals Inc.“Company”“WPD”In the prior press release, WPD disclosed that independent research found 2-deoxy-D-glucose (“2-DGThe Company is not making any express or implied claims that this product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.WPD has not conducted its own research into 2-DG and its efficacy in fighting viral infections. Our Chief Scientific Officer has started the process of preparing protocols for our own research into whether WP1122 can be an effective treatment for viruses, as per our press release dated March 24, 2020 announcing our collaboration with CNS. The publication mentioned in our prior press release is a peer reviewed scientific journal. We accept it as the results of one study, but we must undertake our own research and trials to determine whether WP1122 can achieve results in a clinical setting. WPD is in process of preparing a pr
Show less
Read more
Impact Snapshot
Event Time:
MBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBRX alerts
High impacting Moleculin Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
MBRX
News
- Moleculin Announces Reverse Stock Split [Yahoo! Finance]Yahoo! Finance
- Moleculin to Participate in the Virtual Investor Closing Bell SeriesGlobeNewswire
- Moleculin to execute 1-for-25 reverse stock split [Seeking Alpha]Seeking Alpha
- Moleculin Announces Reverse Stock SplitGlobeNewswire
- Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented [Yahoo! Finance]Yahoo! Finance
MBRX
Analyst Actions
- 9/10/25 - HC Wainwright
MBRX
Sec Filings
- 11/28/25 - Form 8-K
- 11/24/25 - Form 8-K
- 11/21/25 - Form 8-K
- MBRX's page on the SEC website